T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Boston Beer
SAM
$1.9B
| $15.4M | ﹤0.01% |
46,684
-11,269
| -19% | -$4.09M |
|
977
Dime Commercial Bancshares
DCOM
$1.82B
| $15.3M | ﹤0.01% |
480,609
+59,969
| +14% | +$1.98M |
|
978
Masco
MAS
$14.7B
| $15.3M | ﹤0.01% |
327,777
+11,589
| +4% | +$558K |
|
979
National Vision
EYE
$1.51B
| $15.2M | ﹤0.01% |
391,701
-2,246
| -0.6% | -$84.1K |
|
980
UDR
UDR
$12.2B
| $15M | ﹤0.01% |
387,878
+5,078
| +1% | +$201K |
|
|
VMW
981
DELISTED
VMware, Inc
VMW
| $15M | ﹤0.01% |
122,299
+2,344
| +2% | +$270K |
|
982
Globe Life
GL
$14B
| $14.9M | ﹤0.01% |
123,830
+3,825
| +3% | +$437K |
|
|
KYNB
983
Kyntra Bio
KYNB
$28.5M
| $14.9M | ﹤0.01% |
37,125
+35,794
| +2,689% | +$13.7M |
|
984
Braze
BRZE
$3.36B
| $14.6M | ﹤0.01% |
536,761
-1,969,289
| -79% | -$55M |
|
985
Ardagh Metal Packaging
AMBP
$3.16B
| $14.6M | ﹤0.01% |
3,037,668
+59,784
| +2% | +$274K |
|
986
Restaurant Brands International
QSR
$26.7B
| $14.5M | ﹤0.01% |
224,868
+3,405
| +2% | +$209K |
|
|
PAYA
987
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $14.5M | ﹤0.01% |
1,839,455
+1,825,891
| +13,461% | +$14.1M |
|
988
Royal Caribbean
RCL
$82.9B
| $14.4M | ﹤0.01% |
290,916
+7
| +0% | +$367 |
|
|
CMA
989
DELISTED
Comerica
CMA
| $14.1M | ﹤0.01% |
211,599
+4,561
| +2% | +$316K |
|
990
Adaptive Biotechnologies
ADPT
$3.89B
| $14M | ﹤0.01% |
1,838,466
-53,618
| -3% | -$417K |
|
991
Maravai LifeSciences
MRVI
$861M
| $13.9M | ﹤0.01% |
970,525
-328,840
| -25% | -$5.18M |
|
992
Rapid7
RPD
$929M
| $13.9M | ﹤0.01% |
408,134
+52,032
| +15% | +$1.86M |
|
993
Mercury Systems
MRCY
$6.59B
| $13.8M | ﹤0.01% |
308,770
-90,184
| -23% | -$4.27M |
|
|
JNPR
994
DELISTED
Juniper Networks
JNPR
| $13.8M | ﹤0.01% |
432,191
+2,960
| +0.7% | +$89.6K |
|
995
First Bancorp
FBNC
$2.74B
| $13.8M | ﹤0.01% |
321,174
+2,810
| +0.9% | +$123K |
|
996
BorgWarner
BWA
$13.8B
| $13.6M | ﹤0.01% |
383,031
-1,986
| -0.5% | -$67.5K |
|
997
Trex
TREX
$5.1B
| $13.5M | ﹤0.01% |
319,408
-4,740,220
| -94% | -$215M |
|
998
Wayfair
W
$13.9B
| $13.5M | ﹤0.01% |
409,185
-67,852
| -14% | -$2.37M |
|
|
ARCH
999
DELISTED
Arch Resources, Inc.
ARCH
| $13.3M | ﹤0.01% |
93,492
-23,978
| -20% | -$3.51M |
|
1000
Universal Health Services
UHS
$10.1B
| $13.3M | ﹤0.01% |
94,593
-2,620
| -3% | -$309K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.